Business

A digital health program has collected two years of symptom scores, medication logs and free-text diaries. Thousands of entries sit in the database. Somebody asks whether the company now has real-world evidence. It has real data from real people. That...

A rare disease organization launches a form and the response is immediate. Families join from several countries. A clinician offers to share it. A researcher asks how many participants might qualify for a future study. Six months later, the spreadsheet...

The launch date has passed. Devices are in use. Sales has moved on to the next quarter. Then the clinical or regulatory team asks a question that sounds simple and is not: How are we following these patients over time?...

The participant no longer has to drive two hours to the study site. Instead, a package arrives with a wearable, a thermometer and a printed return label. Consent is in one portal. The daily diary is in another app. Telehealth...

The program has an enrollment form, a welcome call and a sequence of refill reminders. On paper, the patient journey is covered. Then a patient skips treatment because the routine no longer fits around work. Another is unsure whether a...

The prototype works. The enclosure is approved. A pilot site is interested. Then somebody on the team asks what happens after the device goes home with the patient. How will the person know whether setup was completed correctly? Where will...

The device works. The clinical service is defined. The operations dashboard is taking shape. Then somebody asks the question that can quietly add a year to the roadmap: What are patients supposed to use? For a smaller health company, the...